Liquid Chromatographic Determination of Cyclophosphamide Enantiomers in Plasma by Precolumn Chiral Derivatization

Joel M. Reid, John F. Stobaugh, Larry A. Sternson

Research output: Contribution to journalArticle

20 Scopus citations


On the basis of reactions described In the synthetic literature, a two-step chiral derivatization sequence was developed for the anticancer agent cyclophosphamide (CP). The sequence involves amidoalkylation of CP with anhydrous chloral containing 1% dimethylformamide followed by acylation of the resulting secondary alcohol with a chiral carboxylic acid chloride, (+)-6-methoxy-α-methyl-2-naphthaleneacetyl chloride, to form a diastereomeric pair. Derivatized (-)-CP and (+)-CP exhibited retention times of 17.2 and 20.7 min, respectively, when chromatographed on Hypersil ODS with acetonitrile/phosphate buffer (pH 6.8) as the mobile phase. Preparation of the individual diastereomers from enantiomerically pure CP enabled correlation of the chromatographically observed peaks with a particular enantlomer. Various aspects of the overall assay methodology have been systematically investigated (derivatization solvents, temperatures, reaction time, and work-up procedures) and optimized on the scale required for trace analysis in biological fluids. Calibration curves were established for each enantiomer in spiked human plasma over the therapeutically relevant concentration range of 0.99-49.94 μg/mL.

Original languageEnglish (US)
Pages (from-to)441-446
Number of pages6
JournalAnalytical Chemistry
Issue number5
StatePublished - Jan 1 1989


ASJC Scopus subject areas

  • Analytical Chemistry

Cite this